iBio
IBIO
#10465
Rank
A$56.93 M
Marketcap
A$1.15
Share price
4.06%
Change (1 day)
-57.38%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): A-$1.17

According to iBio's latest financial reports the company's current EPS (TTM) is A-$1.07. In 2025 the company made an earnings per share (EPS) of A-$2.51 an increase over its 2024 EPS that were of A-$9.31.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.17-53.24%
2025A-$2.51-73.08%
2024A-$9.31-93.88%
2023A-$152.14-8.14%
2022A-$165.6292.67%
2021A-$85.96-80.33%
2020A-$436.97-35.11%
2019A-$673.37-38.96%
2018A-$1,103-6.1%
2017A-$1,17536.67%
2016A-$859.6233.33%
2015A-$644.7250%
2014A-$429.81-53.85%
2013A-$931.26-7.14%
2012A-$1,003-64.1%
2011A-$2,79477.27%
2010A-$1,576144.44%
2009A-$644.7212.93%
2008A-$570.9112.2%
2007A-$508.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.51-1,264.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
A-$0.75-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$9.60 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$4.93 358.67%๐Ÿ‡บ๐Ÿ‡ธ USA